##gff-version 3
##sequence-region P84022 1 425
P84022	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:22814378;Dbxref=PMID:19413330,PMID:22814378	
P84022	UniProtKB	Chain	2	425	.	.	.	ID=PRO_0000090856;Note=Mothers against decapentaplegic homolog 3	
P84022	UniProtKB	Domain	10	136	.	.	.	Note=MH1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00438	
P84022	UniProtKB	Domain	232	425	.	.	.	Note=MH2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00439	
P84022	UniProtKB	Region	137	231	.	.	.	Note=Linker	
P84022	UniProtKB	Region	271	324	.	.	.	Note=Sufficient for interaction with XPO4;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16449645;Dbxref=PMID:16449645	
P84022	UniProtKB	Metal binding	64	64	.	.	.	Note=Zinc	
P84022	UniProtKB	Metal binding	109	109	.	.	.	Note=Zinc	
P84022	UniProtKB	Metal binding	121	121	.	.	.	Note=Zinc	
P84022	UniProtKB	Metal binding	126	126	.	.	.	Note=Zinc	
P84022	UniProtKB	Site	40	40	.	.	.	Note=Required for trimerization	
P84022	UniProtKB	Site	41	41	.	.	.	Note=Required for interaction with DNA and JUN and for functional cooperation with JUN	
P84022	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:22814378;Dbxref=PMID:19413330,PMID:22814378	
P84022	UniProtKB	Modified residue	8	8	.	.	.	Note=Phosphothreonine%3B by CDK2 and CDK4;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15241418;Dbxref=PMID:15241418	
P84022	UniProtKB	Modified residue	179	179	.	.	.	Note=Phosphothreonine%3B by CDK2%2C CDK4 and MAPK;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15241418,ECO:0000269|PubMed:16156666,ECO:0000269|PubMed:19218245;Dbxref=PMID:15241418,PMID:16156666,PMID:19218245	
P84022	UniProtKB	Modified residue	204	204	.	.	.	Note=Phosphoserine%3B by GSK3 and MAPK;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|PROSITE-ProRule:PRU00439,ECO:0000269|PubMed:15241418,ECO:0000269|PubMed:16156666,ECO:0000269|PubMed:19218245;Dbxref=PMID:15241418,PMID:16156666,PMID:19218245	
P84022	UniProtKB	Modified residue	208	208	.	.	.	Note=Phosphoserine%3B by MAPK;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000255|PROSITE-ProRule:PRU00439,ECO:0000269|PubMed:15241418,ECO:0000269|PubMed:16156666,ECO:0000269|PubMed:19218245;Dbxref=PMID:15241418,PMID:16156666,PMID:19218245	
P84022	UniProtKB	Modified residue	213	213	.	.	.	Note=Phosphoserine%3B by CDK2 and CDK4;Ontology_term=ECO:0000255,ECO:0000269;evidence=ECO:0000255|PROSITE-ProRule:PRU00439,ECO:0000269|PubMed:15241418;Dbxref=PMID:15241418	
P84022	UniProtKB	Modified residue	378	378	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16862174;Dbxref=PMID:16862174	
P84022	UniProtKB	Modified residue	416	416	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
P84022	UniProtKB	Modified residue	418	418	.	.	.	Note=Phosphoserine%3B by CK1;Ontology_term=ECO:0000255,ECO:0000269;evidence=ECO:0000255|PROSITE-ProRule:PRU00439,ECO:0000269|PubMed:18794808;Dbxref=PMID:18794808	
P84022	UniProtKB	Modified residue	422	422	.	.	.	Note=Phosphoserine%3B by TGFBR1;Ontology_term=ECO:0000250,ECO:0000255;evidence=ECO:0000250|UniProtKB:Q8BUN5,ECO:0000255|PROSITE-ProRule:PRU00439	
P84022	UniProtKB	Modified residue	423	423	.	.	.	Note=Phosphoserine%3B by TGFBR1;Ontology_term=ECO:0000250,ECO:0000255;evidence=ECO:0000250|UniProtKB:Q8BUN5,ECO:0000255|PROSITE-ProRule:PRU00439	
P84022	UniProtKB	Modified residue	425	425	.	.	.	Note=Phosphoserine%3B by TGFBR1;Ontology_term=ECO:0000250,ECO:0000255;evidence=ECO:0000250|UniProtKB:Q8BUN5,ECO:0000255|PROSITE-ProRule:PRU00439	
P84022	UniProtKB	Cross-link	33	33	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:21947082;Dbxref=PMID:21947082	
P84022	UniProtKB	Cross-link	81	81	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:21947082;Dbxref=PMID:21947082	
P84022	UniProtKB	Alternative sequence	1	195	.	.	.	ID=VSP_045348;Note=In isoform 4. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
P84022	UniProtKB	Alternative sequence	1	105	.	.	.	ID=VSP_043793;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
P84022	UniProtKB	Alternative sequence	1	68	.	.	.	ID=VSP_042900;Note=In isoform 2. MSSILPFTPPIVKRLLGWKKGEQNGQEEKWCEKAVKSLVKKLKKTGQLDELEKAITTQNVNTKCITIP->MSCLHPRQTWKGAALVHRKAWWMG;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
P84022	UniProtKB	Natural variant	112	112	.	.	.	ID=VAR_067051;Note=In LDS3. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21778426;Dbxref=dbSNP:rs387906854,PMID:21778426	
P84022	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_052021;Note=I->V;Dbxref=dbSNP:rs35874463	
P84022	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_067047;Note=In LDS3. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21778426;Dbxref=dbSNP:rs387906853,PMID:21778426	
P84022	UniProtKB	Natural variant	261	261	.	.	.	ID=VAR_065578;Note=In LDS3. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21217753;Dbxref=dbSNP:rs387906851,PMID:21217753	
P84022	UniProtKB	Natural variant	279	279	.	.	.	ID=VAR_067048;Note=In LDS3. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21778426;Dbxref=dbSNP:rs387906852,PMID:21778426	
P84022	UniProtKB	Natural variant	287	287	.	.	.	ID=VAR_065579;Note=In LDS3. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21217753;Dbxref=dbSNP:rs387906850,PMID:21217753	
P84022	UniProtKB	Natural variant	393	393	.	.	.	ID=VAR_036474;Note=In a colorectal cancer sample%3B somatic mutation. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
P84022	UniProtKB	Mutagenesis	8	8	.	.	.	Note=Reduced phosphorylation%2C increased transcriptional and antiproliferative activities. Further increase in transcriptional and antiproliferative activities%3B when associated with V-179 and A-213. T->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15241418;Dbxref=PMID:15241418	
P84022	UniProtKB	Mutagenesis	33	33	.	.	.	Note=Slightly decreased monoubiquitination. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21947082;Dbxref=PMID:21947082	
P84022	UniProtKB	Mutagenesis	40	40	.	.	.	Note=Little effect on interaction with DNA or JUN. Abolishes interaction with DNA and JUN%3B when associated with A-41%3B A-43 and A-44. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10995748;Dbxref=PMID:10995748	
P84022	UniProtKB	Mutagenesis	41	41	.	.	.	Note=Greatly reduced interaction with DNA and JUN. Abolishes interaction with DNA and JUN%3B when associated with A-40%3B A-44 and A-43. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10995748;Dbxref=PMID:10995748	
P84022	UniProtKB	Mutagenesis	43	43	.	.	.	Note=Little effect on interaction with DNA or JUN. Abolishes interaction with DNA and JUN%3B when associated with A-40%3B A-41 and A-44. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10995748;Dbxref=PMID:10995748	
P84022	UniProtKB	Mutagenesis	44	44	.	.	.	Note=Little effect on interaction with DNA or JUN. Abolishes interaction with JUN%3B when associated with A-40%3B A-41 and A-43. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10995748;Dbxref=PMID:10995748	
P84022	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Slightly decreased monoubiquitination. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21947082;Dbxref=PMID:21947082	
P84022	UniProtKB	Mutagenesis	74	74	.	.	.	Note=Reduced interaction with JUN. Loss of transcriptional activity and cooperation with JUN. R->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10995748;Dbxref=PMID:10995748	
P84022	UniProtKB	Mutagenesis	81	81	.	.	.	Note=Decreased monoubiquitination. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21947082;Dbxref=PMID:21947082	
P84022	UniProtKB	Mutagenesis	179	179	.	.	.	Note=Reduced phosphorylation%2C increased transcriptional and increased antiproliferative activities. Further increase in transcriptional and antiproliferative activities%3B when associated with V-8 and A-213. T->V;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15241418,ECO:0000269|PubMed:16156666,ECO:0000269|PubMed:19218245;Dbxref=PMID:15241418,PMID:16156666,PMID:19218245	
P84022	UniProtKB	Mutagenesis	204	204	.	.	.	Note=Increased transcriptional activity. Further increased transcriptional activity%3B when associated with S-208. S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15241418,ECO:0000269|PubMed:16156666,ECO:0000269|PubMed:19218245;Dbxref=PMID:15241418,PMID:16156666,PMID:19218245	
P84022	UniProtKB	Mutagenesis	208	208	.	.	.	Note=Increased transcriptional activity. Further increased transcriptional activity%3B when associated with S-208. S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15241418,ECO:0000269|PubMed:16156666,ECO:0000269|PubMed:19218245;Dbxref=PMID:15241418,PMID:16156666,PMID:19218245	
P84022	UniProtKB	Mutagenesis	213	213	.	.	.	Note=Reduced phosphorylation. Increased transcriptional and antiproliferative activities. Further increase in transcriptional and antiproliferative activities%3B when associated with V-8 and V-179. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15241418;Dbxref=PMID:15241418	
P84022	UniProtKB	Mutagenesis	333	333	.	.	.	Note=No effect on acetylation. Completely abolishes acetylation and 97%25 reduction in transcriptional activity%3B when associated with R-341%3B R-378 and R-409. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16862174;Dbxref=PMID:16862174	
P84022	UniProtKB	Mutagenesis	341	341	.	.	.	Note=No effect on acetylation. Completely abolishes acetylation and 97%25 reduction in transcriptional activity%3B when associated with R-333%3B R-378 and R-409. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16862174;Dbxref=PMID:16862174	
P84022	UniProtKB	Mutagenesis	378	378	.	.	.	Note=Increased transcriptional activity. No further increase in transcriptional activity with EP300. K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16862174;Dbxref=PMID:16862174	
P84022	UniProtKB	Mutagenesis	378	378	.	.	.	Note=Greatly reduced acetylation and 85%25 reduction in transcriptional activity. Completely abolishes acetylation and 97%25 reduction in transcriptional activity%3B when associated with R-333%3B R-341 and R-409. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16862174;Dbxref=PMID:16862174	
P84022	UniProtKB	Mutagenesis	409	409	.	.	.	Note=No effect on acetylation. Completely abolishes acetylation and 97%25 reduction in transcriptional activity%3B when associated with R-333%3B R-341 and R-378. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16862174;Dbxref=PMID:16862174	
P84022	UniProtKB	Mutagenesis	418	418	.	.	.	Note=Increased constitutive activity. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18794808;Dbxref=PMID:18794808	
P84022	UniProtKB	Mutagenesis	418	418	.	.	.	Note=Decreased activity. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18794808;Dbxref=PMID:18794808	
P84022	UniProtKB	Mutagenesis	422	425	.	.	.	Note=Does not abolish protein nuclear export. Abolishes almost completely acetylation. SSVS->AAVA;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11224571,ECO:0000269|PubMed:16449645,ECO:0000269|PubMed:16862174;Dbxref=PMID:11224571,PMID:16449645,PMID:16862174	
P84022	UniProtKB	Mutagenesis	422	425	.	.	.	Note=Forms heterotrimers. SSVS->EEVE;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11224571,ECO:0000269|PubMed:16449645,ECO:0000269|PubMed:16862174;Dbxref=PMID:11224571,PMID:16449645,PMID:16862174	
P84022	UniProtKB	Mutagenesis	422	425	.	.	.	Note=Diminishes cargo protein export. SSVS->RRVR;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11224571,ECO:0000269|PubMed:16449645,ECO:0000269|PubMed:16862174;Dbxref=PMID:11224571,PMID:16449645,PMID:16862174	
P84022	UniProtKB	Sequence conflict	178	178	.	.	.	Note=E->EVGTWAAQAGL;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P84022	UniProtKB	Sequence conflict	360	360	.	.	.	Note=F->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P84022	UniProtKB	Helix	11	17	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5OD6	
P84022	UniProtKB	Helix	25	44	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5OD6	
P84022	UniProtKB	Helix	48	57	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5OD6	
P84022	UniProtKB	Beta strand	60	62	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5OD6	
P84022	UniProtKB	Beta strand	66	68	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5OD6	
P84022	UniProtKB	Beta strand	75	77	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5OD6	
P84022	UniProtKB	Beta strand	80	82	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5OD6	
P84022	UniProtKB	Helix	84	92	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5OD6	
P84022	UniProtKB	Helix	100	102	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5OD6	
P84022	UniProtKB	Beta strand	103	105	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5OD6	
P84022	UniProtKB	Helix	113	115	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5OD6	
P84022	UniProtKB	Beta strand	118	121	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5OD6	
P84022	UniProtKB	Helix	124	126	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5OD6	
P84022	UniProtKB	Beta strand	127	129	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5OD6	
P84022	UniProtKB	Beta strand	221	225	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MK2	
P84022	UniProtKB	Beta strand	231	239	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MJS	
P84022	UniProtKB	Beta strand	242	250	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MJS	
P84022	UniProtKB	Beta strand	252	258	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MJS	
P84022	UniProtKB	Beta strand	268	270	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MJS	
P84022	UniProtKB	Helix	271	273	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1U7F	
P84022	UniProtKB	Helix	281	290	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MJS	
P84022	UniProtKB	Beta strand	294	299	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MJS	
P84022	UniProtKB	Beta strand	302	307	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MJS	
P84022	UniProtKB	Beta strand	309	311	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MJS	
P84022	UniProtKB	Beta strand	313	316	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MJS	
P84022	UniProtKB	Helix	318	321	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MJS	
P84022	UniProtKB	Helix	323	325	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MK2	
P84022	UniProtKB	Beta strand	332	334	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MJS	
P84022	UniProtKB	Beta strand	339	343	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MJS	
P84022	UniProtKB	Helix	345	358	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MJS	
P84022	UniProtKB	Helix	360	364	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MJS	
P84022	UniProtKB	Helix	365	370	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MJS	
P84022	UniProtKB	Beta strand	371	377	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MJS	
P84022	UniProtKB	Beta strand	384	386	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MK2	
P84022	UniProtKB	Helix	389	391	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5XOC	
P84022	UniProtKB	Beta strand	392	400	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MJS	
P84022	UniProtKB	Helix	401	413	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MJS	
